MARATTO

article · British Journal of Clinical Pharmacology

Capacity building in medicines development and regulation in Africa — Overview on recent progress

Abstract

Aims Despite advances in health research and digital innovation, many African countries continue to face substantial resource constraints, fragmented capacity‐building efforts and a shortage of skilled professionals in medicines development and regulatory science. This review explores existing gaps and assesses collaborative approaches to enhancing capacity in this field. It further marks 10 years of sustained contribution by the Fundisa African Academy of Medicines Development towards its advancement. Methods A narrative review was conducted to assess capacity‐building initiatives in medicines development and regulation across Africa. Particular focus was placed on the contributions of the Fundisa African Academy of Medicines Development, in collaboration with partners including academia, clinical research sites, industry and regulatory authorities. Results Capacity‐building efforts across the continent remain heterogeneous and are often implemented in a fragmented manner. Collaborative initiatives, such as those led by the Fundisa African Academy of Medicines Development and its partners, illustrate the potential to mitigate these gaps through accredited training, targeted skills development and experiential learning programmes. Such initiatives support the strengthening of competencies along the entire medicines development continuum, spanning drug discovery, clinical research and regulatory and health economic evaluation. Conclusions Sustainable capacity strengthening in Africa requires coordinated, context‐specific approaches that address the full health research value chain, from investigators to regulatory assessors. Integration of digital health platforms as force multipliers, adoption of standardized competency frameworks such as the WHO Global Competency Framework and development of centralized systems to monitor capacity‐building activities are essential to reduce fragmentation and promote regional collaboration.

Research topics

  • Pharmaceutical Quality and Counterfeiting
  • Global Health and Surgery
  • Pharmaceutical Economics and Policy

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1002/bcp.70770

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.